Perrigo is in the Medical-Generic Drugs Group, they develop, manufactures, markets, and distributes private label self-care products, including cough, cold, and allergy products, analgesics, gastrointestinal products, smoking cessation products, infant formula and food products.
IBD gives it a #1 rank in its industry.
PRGO
made its major low in May while
XLV
made it in late June. That's very good relative strength. Now, after the price broke above its 200-day MA, its been forming a base giving a good opportunity to buy.
The price is making shark pattern with a pivot buy at $43.01. I'll leave a STOP BUY at that level.
IBD gives it a #1 rank in its industry.
PRGO
made its major low in May while
XLV
made it in late June. That's very good relative strength. Now, after the price broke above its 200-day MA, its been forming a base giving a good opportunity to buy. The price is making shark pattern with a pivot buy at $43.01. I'll leave a STOP BUY at that level.
交易結束：達到停損點